Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07116837 · ClinicalTrials.gov registry record · NA
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
A NA study of Vaping, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 3,500
- Enrollment target
- 1
- Study location
NCT07116837: Recruiting NA study of Vaping, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT07116837 is a NA study of Vaping that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 3,500 participants, above the 566-participant average among 18 other Vaping trials with a reported enrollment target (518% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07116837, a NA study of Vaping, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Aim 2 study is to assess the perceived effectiveness of vaping prevention ads among adolescents and young adults and identify which features of video ads predict perceived message effectiveness. Participants will include adolescents aged 13-17 and young adults aged 18-20 who live in the US and who are susceptible to vaping or who currently vape. In an online survey, participants will be randomized to view five randomly selected vaping prevention ads identified from a previous content analysis. After viewing the videos, participants will rate each video on the perceived message effectiveness scale and respond to questions about vaping appeal and urge to vape. The survey will take 15-20 minutes. A follow-up survey of a subset of participants will be conducted around two weeks after they have been exposed to vaping prevention video ads in the baseline survey. Participants will view a total of six videos, including the five videos they watched previously, shown one at a time, along with one "decoy" video ad. After watching each video ad, participants will indicate whether they remember seeing the ad in the survey they took around two weeks prior. The survey will take 10-15 minutes.
Primary Outcome
The 3-item perceived message effectiveness scale assesses the extent to which participants perceived the vaping prevention video ads as effective. Response options are on a 5-point scale from 1="Not at all" to 5="A great deal". The overall scale score is determined by averaging scores from the 3 items, with higher scores representing higher perceived message effectiveness. This is the primary outcome for the main study.
Conditions Studied
Interventions
- BEHAVIORAL Vaping prevention video ads
Study Locations (1)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-07-18 |
| Phase | NA |
What NCT07116837 shows while recruiting
NCT07116837 is an interventional study that assigns participants to a tested intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 566-participant average among 18 other Vaping trials with a reported enrollment target (518% higher).
The record links to 1 condition, with Vaping appearing as the primary indexed condition, and to 1 intervention - of which Vaping prevention video ads is the first listed.
NCT07116837 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07116837 about?
NCT07116837 is a clinical study titled "Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults". The purpose of the Aim 2 study is to assess the perceived effectiveness of vaping prevention ads among adolescents and young adults and identify which features of video ads predict perceived message effectiveness. Participants will include adolescents aged 13-17 and young adults aged 18-20 who live ...
What is the current status of trial NCT07116837?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,500 participants. The study started on 2025-10-01. Estimated completion is 2026-07-18.
What conditions does trial NCT07116837 study?
This clinical trial studies the following conditions: Vaping.
What interventions are being tested in trial NCT07116837?
The interventions under investigation include: Vaping prevention video ads (BEHAVIORAL).
Who is sponsoring clinical trial NCT07116837?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07116837 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07116837's enrollment target sits among peer trials
3,500 2nd of 18 the highest of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
Network Intervention to Prevent Vaping
ACTIVE NOT RECRUITING · NA
-
PACE Vape Messaging Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI